Latest Lead News

Page 248 of 509
Resimac Group has successfully settled a A$1 billion non-conforming residential mortgage backed securities transaction, marking its second such bond issuance this year. The deal attracted strong domestic and offshore investor interest, reinforcing Resimac’s diversified funding strategy.
Claire Turing
Claire Turing
18 Sept 2025
Challenger Limited has announced the Dividend Reinvestment Plan (DRP) issue price for its final 2025 dividend at $8.3615 per share, with a modest 2% participation rate leading to the issuance of approximately 266,000 new shares.
Claire Turing
Claire Turing
18 Sept 2025
Xamble Group Limited has successfully closed a partially underwritten rights issue, raising approximately A$1.36 million to accelerate its digital marketing platform expansion in Southeast Asia.
Sophie Babbage
Sophie Babbage
18 Sept 2025
BCAL Diagnostics has partnered with US-based ClearNote Health to exclusively distribute innovative blood tests for early detection of pancreatic and ovarian cancers in Australia and New Zealand, starting early 2026.
Ada Torres
Ada Torres
18 Sept 2025
Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.
Maxwell Dee
Maxwell Dee
18 Sept 2025
Midas Minerals has raised $11.5 million through a strongly supported placement to fund its acquisition and exploration efforts at the Otavi Copper Project in Namibia.
Maxwell Dee
Maxwell Dee
18 Sept 2025
Western Gold Resources has completed over 45% of its 35,300-metre grade control and infill drilling program at the Gold Duke Project, receiving initial assay results from the Eagle prospect. The company is finalizing an updated scoping study and secured $3 million in non-dilutive funding to support a planned mining start in late 2025.
Maxwell Dee
Maxwell Dee
18 Sept 2025
Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.
Ada Torres
Ada Torres
18 Sept 2025
Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.
Ada Torres
Ada Torres
18 Sept 2025
Mont Royal Resources Ltd (ASX – MRZ) has lodged a prospectus to raise between A$8 million and A$10 million through a share offer priced at A$0.20 each, coinciding with a proposed merger with Commerce Resources Corp (TSXV – CCE). The combined entity aims to become a leading Quebec-focused critical minerals developer.
Maxwell Dee
Maxwell Dee
18 Sept 2025
Lithium Universe Limited reports a major advance in silver recycling technology, achieving near-Britannia-grade purity in just five minutes using its proprietary JESE method. This innovation promises to reshape solar panel recycling with higher efficiency and sustainability.
Maxwell Dee
Maxwell Dee
18 Sept 2025
EQ Resources Limited has appointed industry veteran Craig Bradshaw as Managing Director, marking a strategic leadership transition to drive growth in global tungsten mining.
Maxwell Dee
Maxwell Dee
18 Sept 2025